Exclusive | Ozempic and Mounjaro masked our cancer symptoms — even doctors were unconcerned

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of these wildly popular medications. Brooke Hinderhan thought she had turned a corner with her health. After metformin failed to control her diabetes, doctors prescribed Ozempic. For a time, the popular GLP-1 drug worked, bringing her blood sugar under control. Even the side effects were manageable…

Czech deputy PM laughs off Hillary Clinton’s ‘unhinged’ reaction to his Trump defense in viral, fiery exchange

Hillary Clinton bristled at the Munich Security Conference over the weekend when Czech Deputy Prime Minister Petr Macinka attempted to defend President Trump’s policies.  Clinton raged that Trump has “betrayed the West” and is seeking “unaccountable power” by “modeling himself” after Russian President Vladimir Putin, during a panel discussion at…

SpaceX to compete in Pentagon contest for autonomous drone tech: report

Elon Musk’s SpaceX and its xAI subsidiary are competing in a secret new Pentagon contest to produce voice-controlled, autonomous drone swarming technology, Bloomberg News reported on Monday, citing people familiar with the matter. SpaceX, xAI and the Pentagon’s defense innovation unit did not immediately respond to requests for comment. Reuters could not…

Markets

More
More forecasts: Weather 30 days Sydney